Humanigen Inc

NASDAQ:HGEN   3:59:50 PM EDT
18.43
+0.28 (+1.54%)
4:15:44 PM EDT: $18.45 +0.02 (+0.11%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.09B
Current PEN/A
Forward PE 7.4
2yr Forward PE 5.15
See more stats
Estimates Current Quarter
Revenue$29.98 Million
Adjusted EPS-$0.60
See more estimates
10-Day MA$18.91
50-Day MA$18.58
200-Day MA$18.09
See more pivots

Humanigen Inc Stock, NASDAQ:HGEN

533 Airport Boulevard, Suite 400, Burlingame, California 94005
United States of America
Phone: +1.650.243.3100
Number of Employees: 10

Description

Humanigen, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of cell and gene therapies for the treatment of cancers through novel human granulocyte-macrophage colony-stimulating factor neutralization and gene-knockout platforms. The company was founded by Jeng-Horng Her & Robert F. Balint on March 15, 2000 and is headquartered in Burlingame, CA.